IPO Central

Walpar Nutritions IPO description – Walpar Nutritions offers a wide range of Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness and Food supplement products. The company develops, manufactures and commercializes HERBO-NUTRACEUTICAL products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under Nutraceuticals.

The company has product approvals under the license issued by FSSAI (Food Safety and Standards Authority of India) and AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy) department for manufacturing of Tablets, Capsules, Oral Liquids and Ointments and also for analysis of Chemical, Instrumental & Microbiology.

Walpar has developed more than 100 formulations and 1000 brands for third party for domestic market under different segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Sports nutrition.WALPAR manufactures innovative products comprising of Tablets, Capsules, Liquid Orals, Ointments, Creams, Lotions, Gels and Sachet, powders and effervescent tablets.

Its manufacturing unit is located at 4-9, and 21 at Shyam Estate, Santej, Ta: Kalol, Gandhinagar. At present, the company has installed capacity of manufacturing of approx. 30 Lakhs tablets per month, 12.50 Lakhs capsules per month, 1.50 Lakhs oral liquids of (ranging from 15 ML to 200 ML) per month, and 2.00 Lakhs Sachets of (ranging from 1 gm to 10 gms) per month. It holds WHO, HACCP, HALAL, Kosher and ISO 9001:2015 certificate issued by Independent agencies and has also applied for patents for three products.

Promoters of Walpar Nutritions – Mr Kalpesh Pravinchandra Ladhawala, Mr Tanmaykumar Ashwinbhai Shah And Mrs Sejal Kalpesh Ladhawala